Douglas Pharmaceuticals Executive and Leadership Team

Rod De Spong, the Chief Operating Officer at Douglas Pharmaceuticals, directs all internal manufacturing processes and operational workflows. Overseeing the production facilities in New Zealand, the Chief Operating Officer ensures that every pharmaceutical product meets stringent international quality standards. This leadership role involves optimizing supply chain efficiency to support the company's export-heavy business model. By streamlining production cycles, Rod De Spong directly impacts the scalability of the manufacturing output. The Chief Operating Officer coordinates with the board to align operational capacity with global market demand. Through the implementation of advanced manufacturing technologies, De Spong maintains the competitive edge of the firm. Ultimately, the Chief Operating Officer secures the operational integrity required for sustained growth in the pharmaceutical sector, ensuring that all internal systems function at peak performance levels to deliver high-quality medical solutions to diverse international markets.

Trent Barclay, the Manager, Supply Planning & Chief Marketing Officer, Consumer at Douglas Pharmaceuticals, directs the strategic alignment of consumer-facing product lines with global supply chain capabilities. Overseeing the consumer marketing division, the Manager, Supply Planning & Chief Marketing Officer, Consumer ensures that market demand forecasts directly inform production schedules. This leadership role involves expanding the reach of consumer health products across international territories. By integrating supply planning with consumer engagement strategies, Trent Barclay optimizes inventory turnover and market penetration. The Manager, Supply Planning & Chief Marketing Officer, Consumer collaborates with regional teams to tailor product messaging to specific demographic needs. Through data-driven analysis of consumer trends, Barclay drives the development of targeted marketing campaigns. Ultimately, the Manager, Supply Planning & Chief Marketing Officer, Consumer secures long-term brand loyalty by balancing efficient supply chain management with effective consumer outreach initiatives.

Kylie Fangupo, the Chief Marketing Officer, Planning & Manager, Artwork at Douglas Pharmaceuticals, directs the visual identity and strategic planning for all pharmaceutical packaging and product documentation. Overseeing the artwork department, the Chief Marketing Officer, Planning & Manager, Artwork ensures that every label and insert complies with complex international regulatory requirements. This leadership role involves coordinating with the marketing team to maintain brand consistency across diverse global markets. By managing the intricate artwork approval process, Kylie Fangupo prevents production delays and ensures seamless product launches. The Chief Marketing Officer, Planning & Manager, Artwork integrates planning cycles with design workflows to support the company's export objectives. Through meticulous attention to detail, Fangupo drives the accuracy of all product information. Ultimately, the Chief Marketing Officer, Planning & Manager, Artwork secures the company's reputation for excellence by delivering clear, compliant, and professionally designed product materials to healthcare providers worldwide.

Brent Limmer, the Chief Marketing Officer & Coordinator (Contract Manufacturing ) at Douglas Pharmaceuticals, directs the expansion of contract manufacturing partnerships and the overarching marketing strategy for the firm. Overseeing the contract manufacturing division, the Chief Marketing Officer & Coordinator (Contract Manufacturing ) ensures that external client requirements align with internal production capabilities. This leadership role involves identifying new business opportunities within the global pharmaceutical manufacturing landscape. By fostering strong relationships with international partners, Brent Limmer drives revenue growth through specialized manufacturing services. The Chief Marketing Officer & Coordinator (Contract Manufacturing ) coordinates with the executive team to position the company as a preferred partner for complex pharmaceutical development. Through strategic market positioning, Limmer enhances the visibility of the firm's manufacturing expertise. Ultimately, the Chief Marketing Officer & Coordinator (Contract Manufacturing ) secures the company's financial stability by diversifying the client base and optimizing the utilization of manufacturing assets.

Ceri Rowland, the Chief People Officer at Douglas Pharmaceuticals, directs the human capital strategy and organizational development initiatives. Overseeing the talent acquisition and employee engagement programs, the Chief People Officer ensures that the workforce possesses the specialized skills necessary for high-level pharmaceutical manufacturing. This leadership role involves fostering a culture of innovation and compliance across all departments. By implementing robust training and development frameworks, Ceri Rowland drives employee retention and operational excellence. The Chief People Officer collaborates with the executive team to align human resource policies with the company's long-term growth objectives. Through the management of performance systems, Rowland ensures that every team member contributes effectively to the company's mission. Ultimately, the Chief People Officer secures the organizational health of the firm by attracting top-tier talent and maintaining a high-performance environment that supports the company's status as a leading pharmaceutical manufacturer.